Search Results - Kristi Mclendon
- Showing 1 - 3 results of 3
-
1
A phase 1, randomized, double-blind, placebo-controlled, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of SHR-1905, a long-acting... by Yue Fei, Na Li, Weilin Qian, Yang Fan, Yu Shen, Quanren Wang, Kristi McLendon, Kai Shen
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
A first‐in‐human, randomized study of the safety, pharmacokinetics and pharmacodynamics of povetacicept, an enhanced dual BAFF/APRIL antagonist, in healthy adults by Rupert Davies, Stanford L. Peng, Jason Lickliter, Kristi McLendon, Amanda Enstrom, Allison G. Chunyk, Lori Blanchfield, NingXin Wang, Tiffany Blair, Heather M. Thomas, Alina Smith, Stacey R. Dillon
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
TROIKA‐1: A double‐blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, v... by Martin Demarchi, Pierre Coliat, Kristi Mclendon, Jocelyn Chung Shii Hii, Peggy Feyaerts, Felicia Ang, Litha Jaison, Filip Deforce, Marie Paule Derde, Michael Jinwoo Kim, Lisa Soyeon Park, Alexandre Detappe, Xavier Pivot
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book